Antiepileptic drugs and apoptosis in the developing brain.
about
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childTreatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childNeurodevelopmental effects of fetal antiepileptic drug exposureAn Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment OutcomesBrief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats.Impact of transient acute hypoxia on the developing mouse EEGImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.Neonatal seizures: an update on mechanisms and managementSynergistic neuroprotective therapies with hypothermia.Antiepileptic drugs in women with epilepsy during pregnancyDecreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1.Effects of breastfeeding in children of women taking antiepileptic drugsBumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway.Neonatal Neurocritical Care Service Is Associated With Decreased Administration of Seizure MedicationCognitive outcomes of prenatal antiepileptic drug exposure.Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 miceEffects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.Neonatal exposure to antiepileptic drugs disrupts striatal synaptic developmentNeurological and psychiatric sequelae of developmental exposure to antiepileptic drugs.Developmental effects of antiepileptic drugs and the need for improved regulations.Wrong-way chloride transport: is it a treatable cause of some intractable seizures?Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.Cognitive/behavioral teratogenetic effects of antiepileptic drugs.Effects of in utero antiepileptic drug exposureIssues for new antiepilepsy drug development.Effects of valproate sodium on extracellular signal-regulated kinase 1/2 phosphorylation following hippocampal neuronal epileptiform discharge in rats.Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal ratsFetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.Sodium valproate exposure during the brain growth spurt transiently impairs spatial learning in prepubertal rats.Flavin-containing reductase: new perspective on the detoxification of nitrobenzodiazepine.Effects of exogenous agents on brain development: stress, abuse and therapeutic compounds.Antiepileptic drugs and neurodevelopment: an update.Clinical management of seizures in newborns : diagnosis and treatment.Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
P2860
Q24193032-AA52A448-CDAC-4F7F-87AA-90F4CDB9586CQ24197594-E4D47F8A-0A55-4B98-B3F6-DACDF0552227Q28080703-5A3E62D9-93F4-4222-B128-76C417FA4226Q28081205-1966C516-AB2C-4306-A95A-9FCE7A080B37Q30404972-AA63779C-12FF-4FDD-9BBC-900158BB76F3Q30405327-AFB683B5-D5B3-4E7C-A5DD-686B4F38F677Q30443028-22DE6F17-EFDE-4301-B393-9547B630E798Q30498029-699F306B-436F-4F3F-AB67-989899F1985BQ30585915-44FFA624-7CEF-4180-984F-CAF9FCA4D9A5Q33639690-71C5FC7A-2C6D-4395-B0DC-F08B09F9E283Q33943360-7CFF3C66-3686-4967-BFCB-6E64EFD6AC3CQ33949402-745FBF57-5B34-4136-BCFD-72A2DDAC4C54Q34017315-71445C5D-93DD-4766-9037-6EF2121A5891Q34458170-990B9430-E492-4050-9AB7-8EE01F96E92CQ34638960-12F1EE6E-A123-46F2-A57B-30A6600F623BQ35011452-0B30C5D7-1FB0-49F8-8FFB-900A910994E5Q35042877-C3B3A616-6D93-421F-9603-CC67599E84CFQ35256170-02FDAF14-7D70-4D56-B612-5C03DC772424Q35371452-421E3412-233B-4BC3-8B0C-AA0A2E517CE8Q35582652-FFE478C8-1CB9-46B8-BD76-59DE1D70C26BQ35762249-A6D86CB7-DEC9-4898-A34E-16DF0D44F586Q35783263-03A0DEEE-EE45-42FC-AE5D-07FCA01D52F8Q35883207-DCD38CEF-A56A-46AC-80EF-28801728C882Q36170106-C8136E1B-1474-49A8-9027-7C8E13E484DAQ36490198-ADA89DE3-46E3-434B-AE49-7DC2008E97D9Q36521267-F51D434F-2AC9-4EAF-921F-280959F0B029Q36720976-32D4E86A-C79E-47C2-8F0B-88D2615BFFD4Q36788737-4959A857-26F1-4D8A-9322-02293BF869DDQ36998336-C173CEB3-A7A8-4051-AA9B-2847AE172205Q37029076-D0CC21FD-6D70-42A2-B333-1146173EDE40Q37164052-813B0A42-1F8C-4956-9C9A-BA00486A4775Q37313136-3B889985-F591-4A96-B9B1-96D44BF67BE4Q37408204-A69A6954-E3F6-42D1-AB60-7ABFFBD9EE33Q37515864-BC25BBD6-BAF1-4486-8359-6B8E080A04A9Q37641391-2DC9E640-2FFA-4FB1-BAC0-B35EFB1302A6Q37760940-37C087C6-B661-4FA9-8E82-B0DC1F752118Q37765634-D9F01057-031D-4C37-81B6-458E671F5AFEQ37861591-98D82855-6CCE-4446-85DA-A60B8D4B5BE9Q38075488-A3BE6470-3797-4E1E-A9DA-E5CEF138E8FFQ38086370-AA2210B8-E675-4B9A-B47D-6DB3AA7AD1FD
P2860
Antiepileptic drugs and apoptosis in the developing brain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antiepileptic drugs and apoptosis in the developing brain.
@en
type
label
Antiepileptic drugs and apoptosis in the developing brain.
@en
prefLabel
Antiepileptic drugs and apoptosis in the developing brain.
@en
P1476
Antiepileptic drugs and apoptosis in the developing brain
@en
P2093
Marco Sifringer
Petra Bittigau
P304
103-14; discussion 123-4
P356
10.1111/J.1749-6632.2003.TB07517.X
P407
P50
P577
2003-05-01T00:00:00Z